Novo Nordisk's leadership strategy tested as shareholders signal frustration ahead of vote on board revamp
Novo Nordisk has found itself in an increasingly chaotic situation as of late, with shares plunging and investor confidence waning.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.